These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease. Khayat R; Patt B; Hayes D Heart Fail Rev; 2009 Sep; 14(3):143-53. PubMed ID: 18807180 [TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Wolf J; Lewicka J; Narkiewicz K Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):233-40. PubMed ID: 17314035 [TBL] [Abstract][Full Text] [Related]
15. Which place of pharmacological approaches beyond continuous positive airway pressure to treat vascular disease related to obstructive sleep apnea? Gautier-Veyret E; Pépin JL; Stanke-Labesque F Pharmacol Ther; 2018 Jun; 186():45-59. PubMed ID: 29277633 [TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea: role of intermittent hypoxia and inflammation. May AM; Mehra R Semin Respir Crit Care Med; 2014 Oct; 35(5):531-44. PubMed ID: 25333334 [TBL] [Abstract][Full Text] [Related]
17. Inflammation, oxidative stress, and procoagulant and thrombotic activity in adults with obstructive sleep apnea. Adv Cardiol; 2011; 46():43-66. PubMed ID: 22005189 [TBL] [Abstract][Full Text] [Related]
18. OSA and cardiometabolic risk: What's the bottom line? Hoyos CM; Drager LF; Patel SR Respirology; 2017 Apr; 22(3):420-429. PubMed ID: 28161892 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of endothelial dysfunction in obstructive sleep apnea. Atkeson A; Jelic S Vasc Health Risk Manag; 2008; 4(6):1327-35. PubMed ID: 19337546 [TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Phillips CL; Cistulli PA Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]